Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial

Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide NIH notice explains that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-26T14:13:13.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:59:39.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:43:55.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study record history, indicating an updated submission. The previous revision v3.6.6 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:23.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the record history. The previous Revision: v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-31T17:10:54.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    No additions or deletions are reported in the page history for this study record. Therefore, there are no changes to interpret in this evaluation.
    Difference
    0.1%
    Check dated 2026-08-24T16:49:47.000Z thumbnail image

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.